EXACT SCIENCES CORP (EXAS) Stock Analyst Ratings
USA - NASDAQ:EXAS - US30063P1057 - Common Stock
64.64 USD
-0.21 (-0.32%)
64.64 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 86% to EXAS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 66.4. This target is 2.72% above the current price.
EXAS was analyzed by 31 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about EXAS.
In the previous month the buy percentage consensus was at a similar level.
EXAS was analyzed by 31 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-22 | BTIG | Maintains | Buy -> Buy |
| 2025-10-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-11 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-08-12 | BTIG | Maintains | Buy -> Buy |
| 2025-08-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-08-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-08-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-06-24 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-02 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-05-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-02 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-05-02 | Baird | Maintains | Outperform -> Outperform |
| 2025-04-11 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-10 | Mizuho | Initiate | Outperform |
| 2025-04-10 | Barclays | Maintains | Overweight -> Overweight |
| 2025-03-13 | RBC Capital | Initiate | Sector Perform |
| 2025-02-26 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-02-24 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-02-20 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-20 | B of A Securities | Maintains | Buy -> Buy |
| 2025-01-23 | Barclays | Initiate | Overweight |
| 2025-01-13 | Benchmark | Reiterate | Buy -> Buy |
| 2024-12-13 | B of A Securities | Maintains | Buy -> Buy |
| 2024-11-26 | TD Cowen | Maintains | Buy -> Buy |
| 2024-11-26 | BTIG | Maintains | Buy -> Buy |
EXACT SCIENCES CORP / EXAS FAQ
What is the price target for EXAS stock?
31 analysts have analysed EXAS and the average price target is 66.4 USD. This implies a price increase of 2.72% is expected in the next year compared to the current price of 64.64.
Can you provide the consensus rating for EXACT SCIENCES CORP stock?
The consensus rating for EXACT SCIENCES CORP (EXAS) is 85.8064 / 100 . This indicates that analysts generally have a positive outlook on the stock.